The investigation found that products were being manufactured and supplied outside the legal framework that governs pharmaceutical compounding in South Africa
smegmatis , C
Better outcomes with GLP-1s in those with diabetes and peripheral arterial disease July 29, 2026 Summary: In a propensity-matched observational study of 2,133 pairs of patients with type 2 diabetes and peripheral artery disease, those prescribed GLP-1 receptor agonists had lower five-year rates of death, hospitalization, revascularization, and amputation than those prescribed metformin
Furthermore, this therapy is recognized for promoting skin luminosity, reducing fatigue, supporting neurological health, and providing protective benefits in various chronic conditions.Glutathione Antioxidant Injection by Drip Hydration is recommended for Supporting the treatment of hepatitis and hepatic cirrhosis with its antioxidant and liver-protecting properties
However, there has been increasing concern regarding the possible link between GLP-1 RAs and thyroid cancer